Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment

Disulfiram (DS), an anti-alcoholism medicine, shows strong anti-cancer activity in the laboratory, but the application in clinics for anti-cancer therapy has been limited by its prompt metabolism. Conventional liposomes have shown limited ability to protect DS. Therefore, the aim of this study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Najlah, Mohammad, Said Suliman, Ammar, Tolaymat, Ibrahim, Kurusamy, Sathishkumar, Kannappan, Vinodh, Elhissi, Abdelbary M. A., Wang, Weiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920821/
https://www.ncbi.nlm.nih.gov/pubmed/31739556
http://dx.doi.org/10.3390/pharmaceutics11110610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920821/
https://www.ncbi.nlm.nih.gov/pubmed/31739556
http://dx.doi.org/10.3390/pharmaceutics11110610

Ejemplares similares